Johnson & Johnson faces multibillion opioids lawsuit that could upend big pharma
Oklahoma is suing Johnson & Johnson in a multibillion-dollar lawsuit to hold the drug giant responsible for its opioid addiction epidemic.
Day after day, the memos flashing across screens in an Oklahoma courtroom have jarred with the family-friendly public image of Johnson & Johnson, the pharmaceutical giant best known for baby powder and Band-Aid.
In one missive, a sales representative dismissed a doctor’s fears that patients might become addicted to the company’s opioid painkillers by telling him those who didn’t die probably wouldn’t get hooked. Another proposes targeting sales of the powerfully addictive drugs at those most at risk: men under 40.
As the state of Oklahoma’s multibillion-dollar lawsuit against Johnson & Johnson has unfolded over the past month, the company has struggled to explain marketing strategies its accusers say dangerously misrepresented the risk of opioid addiction to doctors, manipulated medical research, and helped drive an epidemic that has claimed 400,000 lives over the past two decades.
See the original article here: https://www.theguardian.com/us-news/2019/jun/22/johnson-and-johnson-opioids-crisis-lawsuit-latest-trial
About TriMark Legal Funding
TriMark Legal Funding was founded in 2003 and is one of America's foremost legal funding companies. TriMark provides pre settlement funding and settled case funding, sometimes called 'settlement loans', to injured plaintiffs throughout the United States. We offer funding on hundreds of different types of legal claims including personal injury loans, employment litigation funding, work injury accident loans, workers compensation loans, mass tort litigation funding, and multidistrict litigation funding.
We have a sell my structured settlement page for annuitants and we also provide immediate inheritance advance funding for heirs and beneficiaries, as well as legal fee funding for attorneys and law firm financing for legal practices.
|Personal Injury Lawsuits||Other Funding|
Click here to see the original article.